Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

A sensitive and green spectrofluorimetric method for determination of guanfacine hydrochloride based on NBD-Cl derivatization

AI Summary
  • Sensitive NBD-Cl derivatization spectrofluorimetric assay for guanfacine, excitation 466 nm, emission 535 nm, optimised for maximal fluorescence.
  • High sensitivity and linearity across 50–500 ng/mL, r=0.9994, LOD 13.80 ng/mL, LOQ 41.82 ng/mL.
  • ICH-validated, accurate, precise, robust and selective; successfully applied to commercial tablets; greenness confirmed by Eco-scale 89 and AGREE 0.68.
Summarise with AI (MRCPsych/FRANZCP)

Sci Rep. 2026 Aug 9;16(1):24552. doi: 10.1038/s41598-026-64265-6.

ABSTRACT

A sensitive and environmentally friendly spectrofluorimetric method was developed for the determination of guanfacine in pharmaceutical formulations. The method is based on derivatization of guanfacine with 4-chloro-7-nitrobenzofurazan in alkaline medium to yield a highly fluorescent product measured at 535 nm after excitation at 466 nm. Experimental conditions affecting the reaction were systematically optimized to achieve maximum fluorescence intensity. The method exhibited excellent linearity over the concentration range of 50-500 ng/mL with a correlation coefficient of 0.9994. The limits of detection and quantitation were found to be 13.80 and 41.82 ng/mL, respectively, indicating high sensitivity. The method was validated in accordance with ICH guidelines and demonstrated satisfactory accuracy, precision, robustness, and selectivity. It was successfully applied to the analysis of guanfacine in commercial tablet formulations without interference from excipients. Greenness assessment using Analytical Eco-scale and AGREE tools confirmed the environmentally benign nature of the method, achieving a high Eco-scale score of 89 and an AGREE score of 0.68. Compared with a reported method, the proposed approach offers improved sensitivity and superior environmental benignity, making it suitable for routine quality control analysis.

PMID:42572066 | DOI:10.1038/s41598-026-64265-6

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

My Revision List

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review
← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD